RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..2 of 2 - per page
Order by
Apitoxin - new biological drug for pain & inflammation and arthritis
Apitoxin is a new biological drug for pain & inflammation and arthritis, approved by the Korean FDA on May 3, 2003 after 14 years of preclinical, animal, and phase I, II & III clinical studies More
Optimised pulmonary and nasal therapies using supercritical fluid (SCF) particle engineering
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Displaying 1..2 of 2 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
Oct 2010 - 169 pages - $3,500
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Spinal Muscular Atrophy - Pipeline Review, Q4 2010
Dec 2010 - 31 pages - $500
Inflammation Therapy Area Pipeline Report
Nov 2010 - 1336 pages - $1,495
Ocular Inflammation Therapy Area Pipeline Report
Nov 2010 - 205 pages - $1,495
Musculoskeletal Disorders Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
Muscular Dystrophy - Pipeline Assessment and Market Forecasts to 2017
Nov 2010 - 41 pages - $2,000
Autoimmune and Inflammation Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2011
Aug 2011 - 53 pages - $500
Spinal Muscular Atrophy - Pipeline Review, Q2 2011
Apr 2011 - 50 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Therapeutic target
Musculoskeletal del
Muscular del
Inflammation del
Development phase
Phase II del

Browse By

Industry sector
Assay systems
Diagnostic test systems
Gene therapy
Human diagnostics
Human therapeutics
Nanotechnology
Other
Research supplies
Stem cells

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us